SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950115-00-000318
Filing Date
2000-03-14
Accepted
2000-03-14 00:00:00
Documents
7
Period of Report
2000-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 10-Q 66203
2 REGISTRATION RIGHTS AGREEMENT EX-4.1 68163
3 WARRANT EX-4.2 49572
4 WARRANT FOR PURCHASE OF SECURITIES EX-4.3 27255
5 PURCHASE OF SHARES OF COMMON STOCK EX-4.4 27194
6 OPTION AGREEMENT EX-4.5 25096
7 FDS EX-27 2237
  Complete submission text file 0000950115-00-000318.txt   267728
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 569002
SIC: 2834 Pharmaceutical Preparations